China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results

2008-08-07 07:00:00

China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results

    Shanghai, China, Aug. 7 /Xinhua-EMWNews/ -- China-Biotics,

Inc. (OTC Bulletin Board: CHBT), a leading Chinese firm specializing in the

research, development, manufacture, marketing and distribution of

probiotics dietary supplements, today announced it will host a conference

call at 9:00 a.m. EDT on Friday, August 15, 2008, to discuss the Company's

financial results for the first quarter ended June 30, 2008, of its fiscal

2009.



    Hosting the call will be Jinan Song, Chairman and Chief Executive

Officer, Raymond Li, Chief Financial Officer, and Henry Tai, Vice President

of Corporate Development.



    To participate in the event by telephone, please dial (888) 241-0558

five to 10 minutes prior to the start time (to allow time for registration)

and reference the conference ID 58187212. International callers should dial

(647) 427-3417.



    A digital replay of the call will be available on Friday, August 15 at

approximately 11:00 a.m. EDT through Friday, August 22 at midnight EDT. To

listen to the replay, dial (800) 678-0453 and enter the conference ID

number 58187212. International callers should dial (402) 220-1458 and enter

the same conference ID number.



    The conference call will also be webcast live over the Internet and can

be accessed by all interested parties at the company's Web site,

http://www.chn-biotics.com .



    To monitor the live webcast, please go to this web site at least 15

minutes prior to the start of the call to register, download, and install

any necessary audio software. An audio replay of the event will be archived

on China-Biotics' Web site at http://www.chn-biotics.com/ for 90 days.



    About China-Biotics, Inc.



    China-Biotics, Inc. ("China-Biotics," "the Company"), a leading

manufacturer of biotechnology products and supplements, engages in the

research, development, marketing and distribution of probiotics dietary

supplements. Through its wholly owned subsidiary, Shanghai Shining

Biotechnology Co., Ltd., the Company has operations in Shanghai. Its

proprietary product portfolio contains live microbial nutritional

supplements under the "Shining" brand. Currently, the products are sold OTC

through large distributors to pharmacies and supermarkets in Shanghai,

Jiangsu, and Zhejiang. China-Biotics plans to launch 300 Shining brand

stores in major cities in China during the next two years. The Company's

flagship product, "Shining Essence," was approved by the Chinese Ministry

of Health for production and to market as a health product in August 2000,

and it has been a profit driver since its launch in Shanghai in April 2001.

Currently, China-Biotics is strategically expanding its production capacity

of probiotics to meet growing demand in the bulk additive market. For more

information, please visit http://www.chn-biotics.com .



    Safe Harbor Statement Under the Private Securities Litigation Reform

Act of 1995: Any statements set forth above that are not historical facts

are forward-looking statements that involve risks and uncertainties that

could cause actual results to differ materially from those in the

forward-looking statements. Such factors include, but are not limited to,

the Company's ability to market existing and new products, ability to

access to capital for expansion, and changes from anticipated levels of

sales, future national or regional economic and competitive conditions,

market acceptance of its retail store concept, changes in relationships

with customers, dependence on its flagship product profits and other

factors detailed from time to time in the Company's filings with the United

States Securities and Exchange Commission and other regulatory authorities.

The Company undertakes no obligation to publicly update or revise any

forward-looking statements, whether as a result of new information, future

events or otherwise.




For more information, please contact: CCG Investor Relations Crocker Coulson, President Tel: +1-646-213-1915 (New York) Email: crocker.coulson@ccgir.com

Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89

Get Unlimited Organic Website Traffic to your Website 
TheNFG.com now offers Organic Lead Generation & Traffic Solutions





























Leave a Reply

Your email address will not be published. Required fields are marked *

*